ATF bioprocessing equipment for CGTC Braintree comes from Repligen
- Cell and Gene Therapy Catapult
- East of England
- Direct award
- 29 September 2026 to 23 October 2027
Cell and Gene Therapy Catapult is buying non-GMP Alternating Tangential Flow (ATF) equipment from Repligen B.V. for its Braintree site. The equipment will help develop a process that is later due to move into GMP manufacturing.
Repligen's equipment comes with a year's warranty, and the catapult can add a further year of service. The catapult awarded the order directly in July 2026. With the service year, the contract could run to October 2028.
Contract ends October 2027
- What
- Cell analysis and life-science research instruments
- Supplier
- Repligen B.V.
- Value
- Not published
- How it was bought
- Direct award
- Dates and next
- Sep 2026 to Oct 2027
- Option to Oct 2028